CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Cash and Cash Equivalents, Period Increase (Decrease)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$321.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-02-14
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-12-31 was $11.90M, a 72.89% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-09-24 was -$48.86M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-06-25 was -$2.79M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-03-26 was $39.43M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$321.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$42.08M, a 1127.25% decline from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $4.10M, a 91.14% decline from fiscal 2013.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2013 was $46.24M, a 13.39% increase from fiscal 2012.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $11.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$36.96M derived: sum of 2 quarters · filed 2017-02-14 | -$39.75M derived: sum of 3 quarters · filed 2017-02-14 | -$321.00K 10-K · filed 2017-02-14 |
| 2016-09-24 | -$48.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$51.65M derived: sum of 2 quarters · filed 2016-11-02 | -$12.22M 10-Q · filed 2016-11-02 | $31.69M derived: sum of 4 quarters · filed 2017-02-14 |
| 2016-06-25 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $36.64M 10-Q · filed 2016-08-03 | $80.55M derived: sum of 3 quarters · filed 2017-02-14 | $3.78M derived: sum of 4 quarters · filed 2017-02-14 |
| 2016-03-26 | $39.43M 10-Q · filed 2016-05-04 | $83.34M derived: sum of 2 quarters · filed 2017-02-14 | $6.57M derived: sum of 3 quarters · filed 2017-02-14 | $5.46M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-12-26 | $43.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$32.86M derived: sum of 2 quarters · filed 2017-02-14 | -$33.97M derived: sum of 3 quarters · filed 2017-02-14 | -$42.08M 10-K · filed 2017-02-14 |
| 2015-09-26 | -$76.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$77.89M derived: sum of 2 quarters · filed 2016-11-02 | -$85.99M 10-Q · filed 2016-11-02 | -$56.72M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-27 | -$1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$9.22M 10-Q · filed 2016-08-03 | $20.06M derived: sum of 3 quarters · filed 2017-02-14 | $33.80M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-28 | -$8.10M 10-Q · filed 2016-05-04 | $21.17M derived: sum of 2 quarters · filed 2017-02-14 | $34.91M derived: sum of 3 quarters · filed 2017-02-14 | -$17.93M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-27 | $29.28M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $43.01M derived: sum of 2 quarters · filed 2017-02-14 | -$9.83M derived: sum of 3 quarters · filed 2017-02-14 | $4.10M 10-K · filed 2017-02-14 |
| 2014-09-27 | $13.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$39.10M derived: sum of 2 quarters · filed 2015-11-04 | -$25.18M 10-Q · filed 2015-11-04 | $293.00K derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-28 | -$52.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$38.91M 10-Q · filed 2015-07-30 | -$13.44M derived: sum of 3 quarters · filed 2016-02-12 | $3.49M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-29 | $13.92M 10-Q · filed 2015-04-30 | $39.40M derived: sum of 2 quarters · filed 2016-02-12 | $56.33M derived: sum of 3 quarters · filed 2016-02-12 | $69.43M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-28 | $25.47M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $42.41M derived: sum of 2 quarters · filed 2016-02-12 | $55.51M derived: sum of 3 quarters · filed 2016-02-12 | $46.24M 10-K · filed 2016-02-12 |
| 2013-09-28 | $16.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $30.03M derived: sum of 2 quarters · filed 2014-10-30 | $20.77M 10-Q · filed 2014-10-30 | $47.23M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-29 | $13.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $3.84M 10-Q · filed 2014-08-07 | $30.30M derived: sum of 3 quarters · filed 2015-02-17 | $37.45M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-30 | -$9.26M 10-Q · filed 2014-04-30 | $17.20M derived: sum of 2 quarters · filed 2015-02-17 | $24.35M derived: sum of 3 quarters · filed 2015-02-17 | $39.39M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-29 | $26.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $33.61M derived: sum of 2 quarters · filed 2015-02-17 | $48.65M derived: sum of 3 quarters · filed 2015-02-17 | $40.78M 10-K · filed 2015-02-17 |
| 2012-09-29 | $7.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $22.19M derived: sum of 2 quarters · filed 2013-10-30 | $14.32M 10-Q · filed 2013-10-30 | $2.00M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $15.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $7.17M 10-Q · filed 2013-07-31 | -$5.14M derived: sum of 3 quarters · filed 2014-02-25 | -$69.75M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | -$7.87M 10-Q · filed 2013-05-08 | -$20.19M derived: sum of 2 quarters · filed 2014-02-25 | -$84.80M derived: sum of 3 quarters · filed 2014-02-25 | -$97.71M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | -$12.31M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$76.93M derived: sum of 2 quarters · filed 2014-02-25 | -$89.84M derived: sum of 3 quarters · filed 2014-02-25 | -$110.25M 10-K · filed 2014-02-25 |
| 2011-09-24 | -$64.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$77.53M derived: sum of 2 quarters · filed 2012-11-01 | -$97.94M 10-Q · filed 2012-11-01 | -$56.21M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-25 | -$12.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$33.33M 10-Q · filed 2012-08-07 | $8.40M derived: sum of 3 quarters · filed 2013-02-27 | -$73.25M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-26 | -$20.41M 10-Q · filed 2012-05-04 | $21.31M derived: sum of 2 quarters · filed 2013-02-27 | -$60.33M derived: sum of 3 quarters · filed 2013-02-27 | -$63.45M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-25 | $41.73M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$39.92M derived: sum of 2 quarters · filed 2013-02-27 | -$43.04M derived: sum of 3 quarters · filed 2013-02-27 | -$3.41M 10-K · filed 2013-02-27 |
| 2010-09-25 | -$81.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$84.77M derived: sum of 2 quarters · filed 2011-11-02 | -$45.14M 10-Q · filed 2011-11-02 | -$54.77M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-26 | -$3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | $36.50M 10-Q · filed 2011-08-03 | $26.88M derived: sum of 3 quarters · filed 2012-02-27 | $64.27M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-27 | $39.63M 10-Q · filed 2011-05-04 | $30.00M derived: sum of 2 quarters · filed 2012-02-27 | $67.39M derived: sum of 3 quarters · filed 2012-02-27 | |
| 2009-12-26 | -$9.62M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $27.77M derived: sum of 2 quarters · filed 2012-02-27 | -$61.02M 10-K · filed 2012-02-27 | |
| 2009-09-26 | $37.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | -$51.39M 10-Q · filed 2010-11-04 | ||
| 2009-06-27 | -$88.79M 10-Q · filed 2010-08-03 | |||
| 2008-12-27 | $18.14M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |